| Literature DB >> 35329098 |
Rodney P Jones1, Andriy Ponomarenko2.
Abstract
Trends in excess winter mortality (EWM) were investigated from the winter of 1900/01 to 2019/20. During the 1918-1919 Spanish flu epidemic a maximum EWM of 100% was observed in both Denmark and the USA, and 131% in Sweden. During the Spanish flu epidemic in the USA 70% of excess winter deaths were coded to influenza. EWM steadily declined from the Spanish flu peak to a minimum around the 1960s to 1980s. This decline was accompanied by a shift in deaths away from the winter and spring, and the EWM calculation shifted from a maximum around April to June in the early 1900s to around March since the late 1960s. EWM has a good correlation with the number of estimated influenza deaths, but in this context influenza pandemics after the Spanish flu only had an EWM equivalent to that for seasonal influenza. This was confirmed for a large sample of world countries for the three pandemics occurring after 1960. Using data from 1980 onward the effect of influenza vaccination on EWM were examined using a large international dataset. No effect of increasing influenza vaccination could be discerned; however, there are multiple competing forces influencing EWM which will obscure any underlying trend, e.g., increasing age at death, multimorbidity, dementia, polypharmacy, diabetes, and obesity-all of which either interfere with vaccine effectiveness or are risk factors for influenza death. After adjusting the trend in EWM in the USA influenza vaccination can be seen to be masking higher winter deaths among a high morbidity US population. Adjusting for the effect of increasing obesity counteracted some of the observed increase in EWM seen in the USA. Winter deaths are clearly the outcome of a complex system of competing long-term trends.Entities:
Keywords: aging; estimated influenza mortality; obesity; pandemic influenza; season; trends; winter mortality
Mesh:
Substances:
Year: 2022 PMID: 35329098 PMCID: PMC8953800 DOI: 10.3390/ijerph19063407
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Excess winter mortality (EWM) over the past 120 years in Denmark, Sweden, and the USA. Note the Y-axis has been truncated at 100%.
Figure A1Relationship between influenza vaccine doses distributed and proportion vaccinated in various countries (2009–2013) and the time trend for 4 countries (2000 onward). Red and green dashed lines are the upper and lower limits. The blue dotted line is the line of best fit using a third order polynomial. Before 2000 the bulk of countries lie below 150 doses per 1000 population.
Figure 2Month of the year at which the rolling EWM calculation reaches its maximum value in Denmark, month 1 = January, etc.
Figure 3Trend in adjusted monthly deaths in Denmark. Monthly deaths first adjusted to give equal days per month and then adjusted to give an annual total equal to the maximum achieved in 1995.
Figure 4Trend in adjusted EWM for 25 countries (1960 to 2020) plus up to 113 countries and a further 34 states/provinces from Australia, Canada, and Germany (1980 to 2020). Countries are from both the northern and southern hemisphere.
Figure A2Proportion of excess winter deaths (EWD) recorded as “influenza” (ICD codes J10 and J11). Data is from the study of Doshi [11]. Coding practice seem to have changed from 1977 onward and the proportion after this date has been multiplied by 1.8 to compensate.
Figure 5Three different methods for estimating influenza deaths in Denmark, 2010/11 to 2016/17. Influenza deaths are from the study of Nielson et al. [52]. FluMOMO data were adjusted for excess deaths arising from periods of very cold weather. The Goldstein Index method is considered the most reliable method. R-squared for the 3-methods ranges from 0.851 (Positive percent), 0.9178 (Goldstein) to 0.9482 (Influenza-like-illness).
Figure A3Relationship between estimated influenza deaths in Canada versus EWM, 1992–2009. Data is from the study of Schanzer et al. [50]. From 1992 to 2009 there was around 19% growth in deaths. Each year has been adjusted for underlying growth using a polynomial curve fit.
Figure A4Relationship between influenza vaccine doses distributed and adjusted EWM over the winters 1980/81 to 2013/14 (before trimming of high/low values) for a number of northern hemisphere countries. Trimming of high/low values makes little difference (data not shown). Before 2013/14 the bulk of countries lie below 200 doses per 1000 population (20% vaccinated). Dividing the data into three groups of high/medium/low vaccination (17% increments of proportion vaccinated) gives overlapping confidence intervals, and the null hypothesis cannot be excluded. i.e., the slope is zero (data not shown) or no effect can be discerned.
Figure 6Adjusted EWM versus proportion aged 65+ vaccinated in 97 countries, 1988/89 to 2019/20.
Figure 7Trend in excess winter mortality (EWM) in the USA from 1960 to 2020, with and without correction for the effect of influenza vaccination. Vaccine effectiveness before 2003/04 estimated at 40%, actual VE values for 2003/04 onward [54]. Percent elderly vaccinated increases from around 15% in the early 1960s [28] rising to 67% to 70% from 2001 onward [29,30,31,32,33].
Figure A5Trend in excess winter mortality (EWM) from winter 1959/60 to 2019/20 versus proportion aged 65+ vaccinated. Trend lines are given for raw EWM and obesity-adjusted-EWM. The effect of obesity was calculated as a time trend which was matched against proportion aged 65+ vaccinated in that year. Obesity was assumed to have no effect during the 1960s, and half the current effect during the 1970s. The non-linear trends are 4th order polynomials to demonstrate that the overall trend may be more complex than a simple linear trend.
Factors increasing or decreasing EWM with time.
| Factors Increasing EWM with Time | Factors Reducing EWM with Time |
|---|---|
| Multimorbidity—Levels of basic and complex multimorbidity have been increasing over time [ | Home insulation—this is a major contributor to reductions in winter hospitalization and mortality in some countries [ |
| Polypharmacy—Polypharmacy in the Netherlands and USA had more than doubled in the interval 1999 to 2014 [ | Increased access to health care (critical care, antibiotics, antivirals, etc.) and wider public health measures [ |
| Obesity—has been increasing over time [ | Reduced smoking prevalence—smoking leads to inflammation and is a risk factor in influenza mortality [ |
| Alzheimers and dementia—Incidence increases exponentially with age [ | Improvements in influenza vaccine technology such as cell versus egg grown vaccines, adjuvants, etc. [ |
| Diabetes—Incidence increases with age [ | Influenza vaccination in the elderly—increased vaccination will lead to lower influenza deaths [ |
| Cancer—Cancer incidence increases with age [ | |
| Air pollution (especially in large cities with population growth)—Air pollution is well recognized for its ability to increase systemic inflammation [ | |
| Longeivity or increasing age at death—EWM increases with age at death, however, difficult to assess over many decades as chronological age is not a good measure of biological or epigenetic age [ |